Furthermore, it is found that the NF-κB pathway is involved in the IL-1β-induced changes of keratocyte phenotype, and that the selective IKKβ inhibitor TPCA-1, which inhibits NF-κB, can preserve keratocyte phenotype under IL-1β simulated pathological conditions in vitro. 
THERM